Related Experiment Video
Updated: Feb 19, 2026
11:16
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
Published on: February 15, 2019
8.1K
Gene Therapy for Hemophilia: Progress to Date
John C Chapin1, Paul Edward Monahan2
1Shire, 650 Kendall Drive, Cambridge, MA, 02142, USA. john.chapin@shire.com.
Summary
Gene therapy offers a potential cure for hemophilia, a bleeding disorder. Adeno-associated virus (AAV) vectors are used in clinical trials, showing promising long-term factor expression despite immune challenges.
Area of Science:
- Biotechnology
- Hematology
- Gene Therapy
Background:
- Hemophilia is a congenital bleeding disorder affecting millions globally, causing significant debilitation.
- Current treatments are lifelong, costly, and inaccessible to most patients worldwide.
- Gene therapy development for hemophilia has spanned three decades.
Purpose of the Study:
- To review the current status of gene therapy for hemophilia.
- To discuss the adeno-associated virus (AAV) vector technology used in trials.
- To identify challenges and successes in clinical applications.
Main Methods:
- Review of pivotal-stage clinical trials for hemophilia gene therapy.
- Focus on adeno-associated virus (AAV) vector platforms for F8 and F9 transgene delivery.
- Analysis of observed clinical outcomes and immune responses.
Main Results:
- AAV vectors efficiently transduce target tissues like the liver.
- Long-term expression of factors VIII and IX has been achieved in many trial participants.
- Challenges include pre-existing neutralizing antibodies, liver transaminase elevations, and immune-mediated loss of expression.
Conclusions:
- Gene therapy using AAV vectors shows potential as a curative treatment for hemophilia.
- Understanding and overcoming immune responses are critical for therapeutic success.
- This emerging technology offers hope for eliminating severe bleeding and joint damage.
Related Concept Videos
00:59Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
01:29Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
01:29Pharmacogenomics: Identification of New Drug Targets
20
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
20